Contributors


Debra Pratt

Latest:

Lifestyle Changes Can Reduce Breast Cancer Risk

Debra Pratt, from the Cleveland Clinic Breast Health Center, writes that early detection and lifestyle changes can help save lives.


Lindsey M. Lyle, M.S.

Latest:

Comprehensive Visits Following MPN Diagnosis Is Critical

Lindsey M. Lyle, M.S., offers advice to patients with newly diagnosed myeloproliferative neoplasms.




Ilana Cass, M.D.

Latest:

Ilana Cass on Potential Consequences of Preventive Surgery

Ilana Cass, M.D. of Cedars-Sinai Medical Center discusses some of the unknown potential side effects of preventive surgery for ovarian cancer.



ALEX SPIRA, M.D., PH.D., FACP

Latest:

Progress in Sarcoma Treatment, But Still a Long Journey Ahead

New clinical trials have oncologists excited about potential new therapies for patients.


Dr. Guillermo Garcia-Manero

Latest:

Investigational Drug Combination Could Address Unmet Need in TP53-Positive MDS

The phase 3 trial evaluating eprenetapopt plus Vidaza completed enrollment recently, and could lead to a new standard of care with positive results, according to Dr. Guillermo Garcia-Manero.


Amin A. Ramzan, M.D.

Latest:

Opioids Must Be Used Responsibly Amid a National Epidemic

Many patients suffer from chronic pain, making opioids essential for care.


Michael A. Postow

Latest:

Seeing Red

Rash is the most common side effect of cancer immunotherapies, but patients should watch for more serious issues.


Debra Jarvis

Latest:

Prince & the Gun Oil

Sex toys and lubricant and erotic books, oh my!


VERONICA BROWN-MOSELEY, ESQUIRE

Latest:

Financial Healing From Cancer

For some with overwhelming medical expenses, bankruptcy can offer a solution.


Bobbie Chew Bigby

Latest:

The Heart, Soul and Laughter of Healing

An Extraordinary Healer essay honoring MICHELLE GUTIERREZ, RN, OCN [OKLAHOMA CANCER SPECIALISTS AND RESEARCH INSTITUTE, TULSA, OKLAHOMA]


Emily Ward

Latest:

Fighting the Uncertainty of Cancer With Self-Education

A seven-year mesothelioma survivor encourages patients with cancer to be their own advocate.



Nancy Reuben Greenfield

Latest:

Back in Action After DCIS

Treatment options for ductal carcinoma in situ (DCIS), a precursor to breast cancer.


Simone Gampel, RD, CDE

Latest:

Lifestyle Tips for Managing Lymphedema

Lymphedema is a common side effect that may affect a cancer survivor months or even years after treatments such as surgery or radiation therapy. Here are some tips to help manage lymphedema.


Marci Dahl Office Manager, HMS Oncology

Latest:

Moving Mountains to Help Patients - and Staff

An Extraordinary Healer essay honoring IVY BREWSTER, RN, OCN [CHARGE NURSE, ST. JOSEPH HEALTH, HUMBOLDT PEALS FAMILY CHEMOTHERAPY OUTPATIENT CENTER, EUREKA, CALIFORNIA]



Frederic C. Kass

Latest:

Frederic C. Kass on Dealing With Fear Associated With a Cancer Diagnosis

Frederic C. Kass, from the Cancer Center of Santa Barbara, discusses the importance of a multidisciplinary team in dealing with a patient's fear.




Nicholas Esposito

Latest:

The Melanoma Effect

If I ever got sick or injured I would go to the children’s hospital, but that was nothing like a real hospital where people are fighting for their life day-in and day-out. I absolutely hated it, and still do. I was in Emory Hospital visiting my dad two to three times a week for about six months, and every time I walked in that place, it just gave me the heebie-jeebies.


Beth Meagher

Latest:

The Importance of Early Detection in Cancer Care

Beth Meagher, of Deloitte Consulting, discusses the importance of early cancer detection.


Peter Borchmann, M.D.

Latest:

CAR T-Cell Therapy Offers Hope in DLBCL

CAR-T cell therapy is generating excitement for the treatment of diffuse large B-cell lymphoma, according to an update from the JULIET trial.


Eric Kingson

Latest:

What I've Learned About Living Well with Illness

Cancer—the uninvited teacher— leaves a new understanding of what’s important.



Maureen Boesen

Latest:

Making Lemonade: When Life Hands You a BRCA Misdiagnosis

Living with the challenges of having a BRCA1 gene mutation, a woman faces a different struggle when she discovers that diagnosis was wrong.


Trine Alma Knudsen, M.D.

Latest:

Comparing Two MPN Drugs

An expert discusses a trial comparing recombinant interferon alpha-2 with hydroxyurea in patients with myeloproliferative neoplasms (MPNs).


Kristi Rosa

Latest:

Nubeqa Combo Improves Outcomes in Metastatic Prostate Cancer

Nubeqa plus hormone therapy improved outcomes in metastatic prostate cancer, reducing disease progression and showing a favorable safety profile.